Dr Lisa Shaw
Dr Nawaraj Bhattarai
Rachel Cant
Professor Gary Ford
Emeritus Professor Roger Francis
et al. | An extended stroke rehabilitation service for people who have had a stroke: the EXTRAS RCT | 2020 |
|
Dr Steven O'Reilly
Dr Marzena Ciechomska
Rachel Cant
Professor Jaap van Laar
| Interleukin-6 (IL-6) Trans Signaling Drives a STAT3-dependent Pathway That Leads to Hyperactive Transforming Growth Factor-beta (TGF-beta) Signaling Promoting SMAD3 Activation and Fibrosis via Gremlin Protein | 2014 |
|
Dr Steven O'Reilly
Rachel Cant
Dr Marzena Ciechomska
Professor Fiona Oakley
Professor Sophie Hambleton
et al. | Serum Amyloid A (SAA) induces IL-6 in dermal fibroblasts via TLR2, IRAK4 and NF-κB | 2014 |
|
Dr Steven O'Reilly
Rachel Cant
Dr Marzena Ciechomska
James Finnigan
Professor Fiona Oakley
et al. | Serum amyloid A induces interleukin-6 in dermal fibroblasts via Toll-like receptor 2, interleukin-1 receptor-associated kinase 4 and nuclear factor-kappa B | 2014 |
|
Dr Steven O'Reilly
Rachel Cant
Dr Marzena Ciechomska
Professor Jaap van Laar
| Acute Serum Amyloid A (A-SSA) Induces TIMP-1 in Dermal Fibroblasts that is Mediated Via a TLR-Dependent and Formyl Receptor-Independent Pathway | 2013 |
|
Dr Steven O'Reilly
Rachel Cant
Dr Marzena Ciechomska
Professor Jaap Van Laar
| Interleukin-6: a new therapeutic target in systemic sclerosis? | 2013 |
|
Dr Marzena Ciechomska
Rachel Cant
James Finnigan
Professor Jaap Van Laar
Dr Steven O'Reilly
et al. | Role of toll-like receptors in systemic sclerosis | 2013 |
|
